Cited by 179Cell death mechanisms and regulationCancer-related Molecular PathwaysAutophagy in Disease and Therapy

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.

Drug Insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms

Reed, John C·2006·Nature Clinical Practice Oncology

Open this paper in CoChat — free account

Abstract

Cell death is a normal facet of human physiology, ensuring tissue homeostasis by offsetting cell production with cell demise. Neoplasms arise in part because of defects in physiological cell death mechanisms, contributing to pathological cell expansion. Defects in normal cell death pathways also contribute to cancer progression by permitting progressively aberrant cell behaviors, while also desensitizing tumor cells to immune-mediated attack, radiation, and chemotherapy. Through basic research, much has been learned about the molecular mechanisms responsible for cell turnover and how tumors escape cell death. By exploiting this knowledge base, several innovative strategies for eradicating malignancies have materialized that are based on restoration of natural pathways for cell autodestruction. Some of these strategies have advanced into human clinical trials. Several of the current strategies based on targeting core components of the cell death machinery for cancer therapy are reviewed here, and a summary of progress toward clinical applications is provided.

Integrity signals

Registry

Crossref · 10.1038/ncponc0538

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Cell Death
Danial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy
Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X. H., Mizushima, N., Packer, M., Schneider, M. D., & Levine, B. (2005) · Cell · doi:10.1016/j.cell.2005.07.002 · Cited by 3,536
The Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,487
Proliferation, cell cycle and apoptosis in cancer
Evan, G. I., & Vousden, K. H. (2001) · Nature · doi:10.1038/35077213 · Cited by 3,417
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,407
Self-citation
Mitochondrial control of cell death
Kroemer, G., & Reed, J. C. (2000) · Nature Medicine · doi:10.1038/74994 · Cited by 3,103
Self-citation
IAP family proteins---suppressors of apoptosisPreprint
Deveraux, Q. L., & Reed, J. C. (1999) · Genes & Development · doi:10.1101/gad.13.3.239 · Cited by 2,535
Self-citation
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc780 · Cited by 2,476
Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor
Yue, Z., Jin, S., Yang, C., Levine, A. J., & Heintz, N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2436255100 · Cited by 2,116

Flagged first, then by citations

Show all 81 references

Research works printed but not linked: 1

Hyer ML et al.: The FLIP-side of Fas (CD95) signaling. Clin Cancer Res, in press

Sorted by citations

Immunogenic and tolerogenic cell death
Green, D. R., Ferguson, T., Zitvogel, L., & Kroemer, G. (2009) · Nature Reviews Immunology · doi:10.1038/nri2545 · Cited by 1,176
Cell Death
Hotchkiss, R. S., Strasser, A., McDunn, J. E., & Swanson, P. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0901217 · Cited by 1,207
cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination
Bertrand, M. J. M., Milutinovic, S., Dickson, K. M., Ho, W. C., Boudreault, A., Durkin, J. P., Gillard, J. W., Jaquith, J. B., Morris, S. J., & Barker, P. A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.014 · Cited by 1,134
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
Galluzzi, L., Bravo-San Pedro, J. M., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Alnemri, E. S., Altucci, L., Andrews, D., Annicchiarico-Petruzzelli, M., et al. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.137 · Cited by 1,002
To kill a tumor cell: the potential of proapoptotic receptor agonists
Ashkenazi, A., & Herbst, R. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34359 · Cited by 324
Programmed Cell Death Tunes Tumor Immunity
Liu, J., Hong, M., Li, Y., Chen, D., Wu, Y., & Hu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.847345 · Cited by 330
Dissecting lipid raft facilitated cell signaling pathways in cancer
Patra, S. K. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.11.002 · Cited by 318
Autophagy as a therapeutic target in cancer
Chen, N., & Karantza, V. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.2.14622 · Cited by 309
miR‐181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines
Zhu, W., Xia, S., Wang, T., Shu, Y., & Liu, P. (2010) · International Journal of Cancer · doi:10.1002/ijc.25260 · Cited by 302
Apoptosis: A review of pro‐apoptotic and anti‐apoptotic pathways and dysregulation in disease
O'Brien, M., & Kirby, R. (2008) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/j.1476-4431.2008.00363.x · Cited by 253
Mitochondrial signaling in cell death via the Bcl-2 family
Leibowitz, B. J., & Yu, J. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.6.11392 · Cited by 250
MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2
Hu (2010) · Oncology Reports · doi:10.3892/or_00000725 · Cited by 232
Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
Tagscherer, K. E., Fassl, A., Campos, B., Farhadi, M. R., Kraemer, A., Böck, B. C., Macher‐Goeppinger, S., Radlwimmer, B., Wiestler, O. D., Herold‐Mende, C. C., et al. (2008) · Oncogene · doi:10.1038/onc.2008.259 · Cited by 218
miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP
Zhu, W., Xu, H., Zhu, D., Zhi, H., Wang, T., Wang, J., Jiang, B., Shu, Y., & Liu, P. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1752-3 · Cited by 200
Dying cell clearance and its impact on the outcome of tumor radiotherapy
Lauber, K., Ernst, A., Orth, M., i, M. H., & Belka, C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00116 · Cited by 200
Necroptotic cell death in anti‐cancer therapy
Krysko, O., Aaes, T. L., Kagan, V. E., D'Herde, K. G. M. A., Bachert, C., Leybaert, L., Vandenabeele, P., & Krysko, D. V. (2017) · Immunological Reviews · doi:10.1111/imr.12583 · Cited by 180
Degradation of Survivin by the X-linked Inhibitor of Apoptosis (XIAP)-XAF1 Complex
Arora, V. A., Cheung, H. H., Plenchette, S., Micali, O. C., Liston, P., & Korneluk, R. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700776200 · Cited by 163
TRAIL Agonists on Clinical Trials for Cancer Therapy: The Promises and the Challenges
Bellail, A. C., Qi, L., Mulligan, P., Chhabra, V. S., & Hao, C. (2009) · Reviews on Recent Clinical Trials · doi:10.2174/157488709787047530 · Cited by 158
miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2
Zhu, W., Zhu, D., Lu, S., Wang, T., Wang, J., Jiang, B., Shu, Y., & Liu, P. (2012) · Medical Oncology · doi:10.1007/s12032-010-9797-4 · Cited by 189
Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes
Al‐Ejeh, F., Kumar, R., Wiegmans, A. P., Lakhani, S. R., Brown, M. P., & Khanna, K. K. (2010) · Oncogene · doi:10.1038/onc.2010.407 · Cited by 141
Downregulation of BCL2 by miRNAs augments drug induced apoptosis: Combined computational and experimental approach
Singh, R., & Saini, N. (2012) · Journal of Cell Science · doi:10.1242/jcs.095976 · Cited by 131
Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-κB activity in hypoxic tumor cells
Jang, G. Y., Jeon, J. H., Cho, S. Y., Shin, D. M., Kim, C. W., Jeong, E. M., Bae, H.-S., Kim, T. W., Lee, S. H., Choi, Y. H., et al. (2009) · Oncogene · doi:10.1038/onc.2009.342 · Cited by 128
The p53-cathepsin axis cooperates with ROS to activate programmed necrotic death upon DNA damage
Tu, H.-C., Ren, D., Wang, G. X., Chen, D. Y., Westergard, T. D., Kim, H., Sasagawa, S., Hsieh, J. J.-D., & Cheng, E. H. Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808173106 · Cited by 126
Naturally-occurring shikonin analogues – A class of necroptotic inducers that circumvent cancer drug resistance
Xuan, Y., & Hu, X. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.09.029 · Cited by 120
Novel Phosphoinositide 3-Kinase/mTOR Dual Inhibitor, NVP-BGT226, Displays Potent Growth-Inhibitory Activity against Human Head and Neck Cancer Cells In Vitro and In Vivo
Chang, K., Tsai, S.-Y., Wu, C.-M., Yen, C.-J., Chuang, B., & Chang, J. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0796 · Cited by 117
Apoptotic pathways as a therapeutic target for colorectal cancer treatment
Abraha, A. M., & Ketema, E. B. (2016) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v8.i8.583 · Cited by 116
DNA-damage response network at the crossroads of cell-cycle checkpoints, cellular senescence and apoptosis
Schmitt, E., Paquet, C., Beauchemin, M., & Bertrand, R. (2007) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.2007.b0377 · Cited by 117
MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family
Beverly, L. J., & VARMUS, H. E. (2009) · Oncogene · doi:10.1038/onc.2008.466 · Cited by 112
Discovery of 4-Aryl-4H-Chromenes as Potent Apoptosis Inducers Using a Cell- and Caspase-Based Anti-Cancer Screening Apoptosis Program (ASAP): SAR Studies and the Identification of Novel Vascular Disrupting Agents
Cai, S. X., Drewe, J. A., & Kemnitzer, W. E. (2009) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520610909040437 · Cited by 105
Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts.
Patra, S. K., Rizzi, F., Silva, A., Rugină, D. O., & Bettuzzi, S. (2008) · PubMed · Cited by 103
Towards Solid Tumor Treatment by Irreversible Electroporation: Intrinsic Redistribution of Fields and Currents in Tissue
Esser, A. T., Smith, K. C., Gowrishankar, T. R., & Weaver, J. C. (2007) · Technology in Cancer Research & Treatment · doi:10.1177/153303460700600402 · Cited by 101
Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression
Ivanov, V. N., Partridge, M. A., Johnson, G. E., Huang, S. X. L., Zhou, H., & Hei, T. K. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.12.012 · Cited by 100
Transcriptional regulation of cellular senescence
Lanigan, F., Geraghty, J. G., & Bracken, A. P. (2011) · Oncogene · doi:10.1038/onc.2011.34 · Cited by 95
Recent Insights into the Biological Action of Heavy-Ion Radiation
Hamada, N. (2009) · Journal of Radiation Research · doi:10.1269/jrr.08070 · Cited by 94
Immunogenic and Non-immunogenic Cell Death in the Tumor Microenvironment
Pitt, J. M., Kroemer, G., & Zitvogel, L. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67577-0_5 · Cited by 98
From nature to bedside: Pro-survival and cell death mechanisms as therapeutic targets in cancer treatment
Cerella, C., Teiten, M.-H., Radogna, F., Dicato, M. A., & Diederich, M. F. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.03.006 · Cited by 95
Big wheel keeps on turning: apoptosome regulation and its role in chemoresistance
Fadeel, B., Ottosson, A., & Pervaiz, S. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402265 · Cited by 95
Sorafenib Inhibits STAT3 Activation to Enhance TRAIL-Mediated Apoptosis in Human Pancreatic Cancer Cells
Huang, S., & Sinicrope, F. A. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1004 · Cited by 93
Image Analysis Algorithms for Immunohistochemical Assessment of Cell Death Events and Fibrosis in Tissue Sections
Krajewska, M., Smith, L. H., Rong, J., Huang, X., Hyer, M. L., Zeps, N., Iacopetta, B. J., Linke, S. P., Olson, A. H., Reed, J. C., et al. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.952812 · Cited by 89
Self-citation
Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy
Meng, M.-B., Wang, H.-H., Cui, Y.-L., Wu, Z.-Q., Shi, Y., Zaorsky, N. G., Deng, L., Yuan, Z., Lü, Y., & Wang, P. (2016) · Oncotarget · doi:10.18632/oncotarget.10548 · Cited by 91
BH3 Mimetic Obatoclax Enhances TRAIL-Mediated Apoptosis in Human Pancreatic Cancer Cells
Huang, S., Okumura, K., & Sinicrope, F. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1575 · Cited by 86
Apoptosis and cancer stem cells: Implications for apoptosis targeted therapy
Kruyt, F. A. E., & Schuringa, J. J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.04.010 · Cited by 88
miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2
Qiu, T., Zhou, L. Q., Wang, T., Xu, J., Wang, J., Chen, W., Xin Min, Z. H. O. U., Huang, Z., Zhu, W., Shu, Y., et al. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1439 · Cited by 85
Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. Part 1: Structure–activity relationships of the 1- and 3-positions
Kemnitzer, W. E., Kuemmerle, J., Jiang, S., Zhang, H., Sirisoma, N. S., Kasibhatla, S., Crogan‐Grundy, C., Tseng, B., Drewe, J. A., & Cai, S. X. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.09.110 · Cited by 83
Human umbilical cord matrix-derived stem cells expressing interferon-β gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice
Matsuzuka, T., Rachakatla, R. S., Doi, C., Maurya, D. K., Ohta, N., Kawabata, A., Pyle, M. M., Pickel, L., Reischman, J., Marini, F. C., et al. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.01.003 · Cited by 83
Discovery of 4-aryl-2-oxo-2H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay
Kemnitzer, W. E., Jiang, S., Zhang, H., Kasibhatla, S., Crogan‐Grundy, C., Blais, C., Attardo, G., Denis, R. C., Lamothe, S., Gourdeau, H., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.09.011 · Cited by 78
A Chemical Screen Identifies Anisomycin as an Anoikis Sensitizer That Functions by Decreasing FLIP Protein Synthesis
Mawji, I. A., Simpson, C. D., Gronda, M., Williams, M. A., Hurren, R., Henderson, C. J., Datti, A., Wrana, J. L., & Schimmer, A. D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1687 · Cited by 78
Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by Ubiquilin1
Beverly, L. J., Lockwood, W. W., Shah, P. P., Erdjument‐Bromage, H., & VARMUS, H. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119167109 · Cited by 73
Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes
Shkreta, L., Froehlich, U., Paquet, É. R., Toutant, J., Elela, S. A., & Chabot, B. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0192 · Cited by 69
Ecology‐based screen identifies new metabolites from a Cordyceps‐colonizing fungus as cancer cell proliferation inhibitors and apoptosis inducers
Chen, Y., Guo, H., Du, Z., Liu, X., Che, Y., & Ye, X. (2009) · Cell Proliferation · doi:10.1111/j.1365-2184.2009.00636.x · Cited by 66
Apoptosis and Compensatory Proliferation Signaling Are Coupled by CrkI-Containing Microvesicles
Gupta, K. H., Goldufsky, J. W., Wood, S. J., Tardi, N. J., Moorthy, G. S., Gilbert, D. Z., Zayas, J. P., Hahm, E., Altintas, M. M., Reiser, J., et al. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.05.014 · Cited by 62
Over-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells
Pickel, L., Matsuzuka, T., Doi, C., Ayuzawa, R., Maurya, D. K., Xie, S., Berkland, C. J., & Tamura, M. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.4.10643 · Cited by 59
The Multifaceted Roles of the BCL-2 Family Member BOK
Naim, S., & Kaufmann, T. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.574338 · Cited by 57
The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms
Llobet‐Navàs, D., Eritja, N., Yeramian, A., Pallares, J., Sorolla, A., Domingo, M., Santacana, M., Gonzalez-Tallada, F. J., Matías‐Guiu, X., & Dolcet, X. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.12.025 · Cited by 55
Cell death pathology: Perspective for human diseases
Agostini, M., Tucci, P., & Melino, G. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.081 · Cited by 55
Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer
Ingemarsdotter, C. K., Baird, S. K., Connell, C. M., Öberg, D., Halldén, G., & McNeish, I. A. (2010) · Oncogene · doi:10.1038/onc.2010.335 · Cited by 56
Mitotic arrest and JNK-induced proteasomal degradation of FLIP and Mcl-1 are key events in the sensitization of breast tumor cells to TRAIL by antimicrotubule agents
Sánchez‐Pérez, T., Ortiz-Ferrón, G., & López‐Rivas, A. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.176 · Cited by 53
BAK activation is necessary and sufficient to drive ceramide synthase-dependent ceramide accumulation following inhibition of BCL2-like proteins
Beverly, L. J., Howell, L. A., Hernandez‐Corbacho, M. J., Casson, L. K., Chipuk, J. E., & Siskind, L. J. (2013) · Biochemical Journal · doi:10.1042/bj20130147 · Cited by 52
Antagonism of Inhibitor of Apoptosis Proteins Increases Bone Metastasis via Unexpected Osteoclast Activation
Yang, C., Davis, J. L., Zeng, R., Vora, P., Su, X., Collins, L. I., Vangveravong, S., Mach, R. H., Piwnica-Worms, D., Weilbaecher, K. N., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0271 · Cited by 50
TAK1 kinase determines TRAIL sensitivity by modulating reactive oxygen species and cIAP
Morioka, S., Omori, E., Kajino, T., Kajino‐Sakamoto, R., Matsumoto, K., & Ninomiya‐Tsuji, J. (2009) · Oncogene · doi:10.1038/onc.2009.110 · Cited by 49
Heat stress induced cell death mechanisms in hepatocytes and hepatocellular carcinoma: In vitro and in vivo study
Thompson, S. M., Callstrom, M. R., Butters, K. A., Knudsen, B. E., Grande, J. P., Roberts, L. R., & Woodrum, D. A. (2014) · Lasers in Surgery and Medicine · doi:10.1002/lsm.22231 · Cited by 48
Disruption of IGF-1R signaling increases TRAIL-induced apoptosis: A new potential therapy for the treatment of melanoma
Karasic, T. B., Hei, T. K., & Ivanov, V. N. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.014 · Cited by 47
Genomics and Cancer Drug Resistance
Rodrigues, A. S., Dinis, J., Gromicho, M., Martins, C., Laires, A., & Rueff, J. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112799857549 · Cited by 47
Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention
Flinsenberg, T. W. H., Compeer, E. B., Boelens, J. J., & Boes, M. L. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04411.x · Cited by 43
Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells
Karaca, B., Atmaca, H., Bozkurt, E., Kısım, A., Uzunoğlu, S., Karabulut, B., Sezgin, C., Şanlı, U. A., & Uslu, R. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2469-z · Cited by 42
Death receptor expression is associated with poor response to chemotherapy and shorter survival in metastatic ovarian carcinoma
Dong, H. P., Kleinberg, L., Silins, I., Flørenes, V. A., Trope, C. G., Risberg, B. Å., Nesland, J. M., & Davidson, B. (2007) · Cancer · doi:10.1002/cncr.23140 · Cited by 42
Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2: Structure–activity relationships of the 4-, 5-, 6-, 7- and 8-positions
Kemnitzer, W. E., Kuemmerle, J., Jiang, S., Sirisoma, N. S., Kasibhatla, S., Crogan‐Grundy, C., Tseng, B., Drewe, J. A., & Cai, S. X. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.012 · Cited by 41
RETRACTED: CD133+/CD44+/Oct4+/Nestin+ stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic cancer
Wang, D., Zhu, H., Zhu, Y., Liu, Y., Shen, H., Yin, R.-G., Zhang, Z., & Su, Z. (2012) · Acta Histochemica · doi:10.1016/j.acthis.2012.09.007 · Cited by 40
Retracted
Apoptosis regulators as targets for cancer therapy
Fernández-Luna, J. L. (2007) · Clinical & Translational Oncology · doi:10.1007/s12094-007-0103-7 · Cited by 40
Nuclear Survivin Abrogates Multiple Cell Cycle Checkpoints and Enhances Viral Oncolysis
Connell, C. M., Wheatley, S. P., & McNeish, I. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0817 · Cited by 40
P2X 7 -mediated chemoprevention of epithelial cancers
Gorodeski, G. I. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903277249 · Cited by 38
Cell Death and Deubiquitinases: Perspectives in Cancer
Bhattacharya, S., & Ghosh, M. K. (2014) · BioMed Research International · doi:10.1155/2014/435197 · Cited by 38
Energetic heavy ions overcome tumor radioresistance caused by overexpression of Bcl-2
Hamada, N., Hara, T., Omura‐Minamisawa, M., Funayama, T., Sakashita, T., Sora, S., Yokota, Y., Nakano, T., & Kobayashi, Y. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.02.013 · Cited by 36
In vivo Targeting of Dead Tumor Cells in a Murine Tumor Model Using a Monoclonal Antibody Specific for the La Autoantigen
Al‐Ejeh, F., Darby, J. M., Pensa, K., Diener, K. R., Hayball, J. D., & Brown, M. P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0964 · Cited by 36
Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism
Ortiz-Ferrón, G., Yerbes, R., Eramo, A., López-Pérez, A. I., Maria, R. D., & López‐Rivas, A. (2008) · Cell Research · doi:10.1038/cr.2008.54 · Cited by 35
Identifying Apoptosis-Evasion Proteins/Pathways in Human Hepatoma Cells via Induction of Cellular Hormesis by UV Irradiation
Hsieh, S., Hsu, C., He, J., Liu, C.-L., Lo, S., Chen, Y.-C., & Huang, H. (2009) · Journal of Proteome Research · doi:10.1021/pr900289g · Cited by 35
Implications of endoplasmic reticulum stress, the unfolded protein response and apoptosis for molecular cancer therapy. Part I: targeting p53, Mdm2, GADD153/CHOP, GRP78/BiP and heat shock proteins
Hiss, D. C., & Gabriels, G. A. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903052559 · Cited by 35
Regulation of apoptosis in human melanoma and neuroblastoma cells by statins, sodium arsenite and TRAIL: a role of combined treatment versus monotherapy
Ivanov, V. N., & Hei, T. K. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0649-2 · Cited by 34
Blockade of MGMT Expression by O6 Benzyl Guanine Leads to Inhibition of Pancreatic Cancer Growth and Induction of Apoptosis
Konduri, S. D., Ticku, J., Bobustuc, G. C., Sutphin, R. M., Colon, J. F., Isley, B. A., Bhakat, K. K., Kalkunte, S. S., & Baker, C. H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0887 · Cited by 34
Chemotherapy Synergizes with Radioimmunotherapy Targeting La Autoantigen in Tumors
Al‐Ejeh, F., Darby, J. M., & Brown, M. P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004630 · Cited by 33
Clearance of primary necrotic cells by non‐professional phagocytes
Schwegler, M., Wirsing, A. M., Dollinger, A. J., Abendroth, B., Putz, F., Fietkau, R., & Distel, L. V. (2015) · Biology of the Cell · doi:10.1111/boc.201400090 · Cited by 31
Micro-Economics of Apoptosis in Cancer: ncRNAs Modulation of BCL-2 Family Members
Villanova, L., Careccia, S., Maria, R. D., & Fiori, M. E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040958 · Cited by 31
The Bcl-w promoter is activated by β-catenin/TCF4 in human colorectal carcinoma cells
Lapham, A. S., Adams, J. E., Paterson, A. R., Lee, M., Brimmell, M., & Packham, G. (2008) · Gene · doi:10.1016/j.gene.2008.12.002 · Cited by 30
Structure Determinants of Lagunamide A for Anticancer Activity and Its Molecular Mechanism of Mitochondrial Apoptosis
Huang, X., Huang, W., Li, L., Sun, X., Song, S., Xu, Q., Zhang, L., Wei, B., & Deng, X. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00564 · Cited by 30
Cutting-Edge Apoptosis-Based Therapeutics
Fischer, U., Janssen, K., & Schulze‐Osthoff, K. (2007) · BioDrugs · doi:10.2165/00063030-200721050-00001 · Cited by 29
Identification of Novel Formyl Peptide Receptor-Like 1 Agonists That Induce Macrophage Tumor Necrosis Factor α Production
Schepetkin, I. A., Kirpotina, L. N., Tian, J., Khlebnikov, А. I., Ye, R. D., & Quinn, M. T. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046946 · Cited by 28
Expression of p53 and DR5 in normal and malignant tissues of colorectal cancer: Correlation with advanced stages
Perraud, A. (2011) · Oncology Reports · doi:10.3892/or.2011.1404 · Cited by 28
Inhibition of SREBP1 sensitizes cells to death ligands
Eberhard, Y., Gronda, M., Hurren, R., Datti, A., MacLean, N., Ketela, T., Moffat, J., Wrana, J. L., & Schimmer, A. D. (2011) · Oncotarget · doi:10.18632/oncotarget.239 · Cited by 28
Biocompatibility, absorption and safety of protein nanoparticle-based delivery of doxorubicin through oral administration in rats
Golla, K., Reddy, P. S., Bhaskar, C., & Kondapi, A. K. (2013) · Drug Delivery · doi:10.3109/10717544.2013.801051 · Cited by 28
Targeting regulated cell death pathways in cancers for effective treatment: a comprehensive review
Saxena, R., Welsh, C. M., & He, Y.-W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1462339 · Cited by 29
Human umbilical cord matrix-derived stem cells expressing interferon-β gene inhibit breast cancer cells via apoptosis
Shen, C., Chan, T., Chen, C.-C., Hsu, Y., Long, C., & Lai, C. (2016) · Oncotarget · doi:10.18632/oncotarget.8997 · Cited by 27
Potential antitumor agent from the endophytic fungus Pestalotiopsis photiniae induces apoptosis via the mitochondrial pathway in HeLa cells
Chen, C., Hu, S., Luo, D., Zhu, S., & Zhou, C. (2013) · Oncology Reports · doi:10.3892/or.2013.2618 · Cited by 25
Effect of physical exercise on tumor growth regulating factors of tumor microenvironment: Implications in exercise-dependent tumor growth retardation
Verma, V. K., Singh, V., Singh, M. P., & Singh, S. M. (2009) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923970802562042 · Cited by 25
Spy1 induces de-ubiquitinating of RIP1 arrest and confers glioblastoma's resistance to tumor necrosis factor (TNF-α)-induced apoptosis through suppressing the association of CLIPR-59 and CYLD
Ding, Z., Liu, Y., Li, Y., Wang, D., Zhang, J., Cui, G., Yang, X., Huang, X., Liu, F., & Shen, A. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1041688 · Cited by 24
Inhibition of novel protein kinase Cɛ augments TRAIL-induced cell death in A549 lung cancer cells
Felber, M., Sonnemann, J., & Beck, J. F. (2007) · Pathology & Oncology Research · doi:10.1007/bf02940308 · Cited by 24
Immunogenic Cell Death Role in Urothelial Cancer Therapy
Yadollahvandmiandoab, R., Jalalizadeh, M., Buosi, K., García‐Perdomo, H. A., & Reis, L. O. (2022) · Current Oncology · doi:10.3390/curroncol29090526 · Cited by 23
CD95 signaling in colorectal cancer
Hoogwater, F. J. H., Steller, E. J. A., Westendorp, B. F., Rinkes, I. H. M. B., & Kranenburg, O. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.03.007 · Cited by 23
Discovery of N-aryl-9-oxo-9H-fluorene-1-carboxamides as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure–activity relationships of the 9-oxo-9H-fluorene ring
Kemnitzer, W. E., Sirisoma, N. S., Jiang, S., Kasibhatla, S., Crogan‐Grundy, C., Tseng, B., Drewe, J. A., & Cai, S. X. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.025 · Cited by 23
Promising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology
Joshi, N., Biswas, J., Nath, C., & Singh, S. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8865-8 · Cited by 22
New determinates of disease progression and outcome in metastatic ovarian carcinoma.
Davidson, B., Reich, R., Trope, C. G., Wang, T., & Shih, I. (2010) · PubMed · doi:10.14670/hh-25.1591 · Cited by 22

Authors: Reed, J. C.
Affiliations: Sanford Burnham Prebys Medical Discovery Institute (US)
Corresponding author: Reed, John C
ORCID: Reed, John C
Venue: Nature Clinical Practice Oncology
Publisher: Springer Science and Business Media LLC
Published: 2006-07
Volume: 3
Issue: 7
Pages: 388-398
ISSN: 1743-4254 (ISSN-L)
1743-4262
DOI: 10.1038/ncponc0538
OpenAlex: W2125192217
Cited by: 179
References: 81
Citations by year: 2026: 1 · 2025: 1 · 2024: 4 · 2023: 3 · 2022: 2 · 2020: 5 · 2018: 2 · 2017: 7 · 2016: 5 · 2015: 14 · 2014: 7 · 2013: 9 · 2012: 11
FWCI: 1.97
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Clinical Practice Oncology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Keywords: cancer therapy, cell death pathways, apoptosis, epigenetic regulators, gene therapy, tumor immune evasion, tumor progression, clinical trials, cell turnover
MeSH terms: Antineoplastic Agents, Clinical Trials as Topic, Humans, Mitochondria, Neoplasms, Signal Transduction, Cell Death, Apoptosis, Apoptosis Regulatory Proteins, Inhibitor of Apoptosis Proteins, TNF-Related Apoptosis-Inducing Ligand

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Drug Insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks